[Lymph node metastasis as a prognostic factor in cervical carcinoma]
- PMID: 12722375
[Lymph node metastasis as a prognostic factor in cervical carcinoma]
Abstract
Material and methods: 499 patients with cervical carcinoma at stage I and IIa after radical hysterectomy were included in the study. Diagnosis was based on gynecological examinations and cervical biopsies. Clinical staging was determined by FIGO classification. Pelvic lymph nodes were routinely removed on hysterectomy.
Results: Metastatic nodes were observed in 26.3% (131 patients). We found no metastatic nodes at stage Ia. In the group of 410 patients with stage Ib cervical cancer metastases in lymph nodes were found in 24.6% (101 patients). In the group of 78 patients with stage IIa cervical cancer metastatic nodes were observed in 38.5% (30 patients). In our finding metastases were located in one group of lymph nodes in 64.4% (64 patients) with stage Ib and 43.3% (13 patients) with stage IIa. Metastatic involvement of more than one group of lymph nodes was observed in 36.6% (37 patients) of stage Ib and 56.7% (17 patients) of stage IIa. The most frequent pattern of lymph nodes metastatic involvement comprised common iliac and obturatorious nodes. 5 year survival in the group without metastases in lymph nodes was estimated at 82.2%, and in the group with nodal metastases--50.8% (p = 0.005).
Conclusions: 1. Metastases to pelvic lymph nodes are significant prognostic factor of long-term survival in patients with cervical cancer. 2. Patients with metastases in lymph nodes and no subsequent postoperative radiotherapy had significantly worse long-term survival.
Similar articles
-
Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.Cancer. 1997 Oct 1;80(7):1234-40. Cancer. 1997. PMID: 9317173
-
High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.Gynecol Oncol. 2000 May;77(2):305-9. doi: 10.1006/gyno.2000.5788. Gynecol Oncol. 2000. PMID: 10785483
-
[The rule of metastatic pelvic lymph node distribution in patients with early stage cervical carcinoma].Zhonghua Zhong Liu Za Zhi. 2008 Jun;30(6):452-5. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19024522 Chinese.
-
Identification of high-risk groups among node-positive patients with stage IB and IIA cervical carcinoma.Gynecol Oncol. 1997 Mar;64(3):463-7. doi: 10.1006/gyno.1996.4576. Gynecol Oncol. 1997. PMID: 9062151 Review.
-
Why do we continue to overtreat stage Ia carcinoma of the cervix?Am J Obstet Gynecol. 2017 Oct;217(4):413-417. doi: 10.1016/j.ajog.2017.05.020. Epub 2017 May 15. Am J Obstet Gynecol. 2017. PMID: 28522321 Review.
Cited by
-
Solamargine Alleviates Proliferation and Metastasis of Cervical Cancer Cells by Blocking the CXCL3-Mediated Erk Signaling Pathway.Evid Based Complement Alternat Med. 2022 Oct 29;2022:7634754. doi: 10.1155/2022/7634754. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36345403 Free PMC article.
-
Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.Cancer Manag Res. 2021 Dec 29;13:9391-9400. doi: 10.2147/CMAR.S336892. eCollection 2021. Cancer Manag Res. 2021. PMID: 35002316 Free PMC article.